Laura Dal Bo

851 total citations
20 papers, 724 citations indexed

About

Laura Dal Bo is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Laura Dal Bo has authored 20 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Laura Dal Bo's work include Sarcoma Diagnosis and Treatment (4 papers), ATP Synthase and ATPases Research (3 papers) and Metal complexes synthesis and properties (3 papers). Laura Dal Bo is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), ATP Synthase and ATPases Research (3 papers) and Metal complexes synthesis and properties (3 papers). Laura Dal Bo collaborates with scholars based in Italy, United States and South Korea. Laura Dal Bo's co-authors include Franco Zunino, Nives Carenini, Chiara Giommarelli, Gabriele Fontana, Federica Belluti, Franco Zunino, Paola Perego, Giovanni Capranico, Monica Binaschi and Monica Tortoreto and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Laura Dal Bo

20 papers receiving 701 citations

Peers

Laura Dal Bo
Xin‐Jie Chu United States
Tanya Coleman United Kingdom
Xuewei Wu China
Laura Dal Bo
Citations per year, relative to Laura Dal Bo Laura Dal Bo (= 1×) peers Wen‐Hsing Lin

Countries citing papers authored by Laura Dal Bo

Since Specialization
Citations

This map shows the geographic impact of Laura Dal Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Dal Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Dal Bo more than expected).

Fields of papers citing papers by Laura Dal Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Dal Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Dal Bo. The network helps show where Laura Dal Bo may publish in the future.

Co-authorship network of co-authors of Laura Dal Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Dal Bo. A scholar is included among the top collaborators of Laura Dal Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Dal Bo. Laura Dal Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanzi, Cinzia, Enrica Favini, Laura Dal Bo, et al.. (2021). Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma. Journal of Experimental & Clinical Cancer Research. 40(1). 381–381. 12 indexed citations
2.
3.
Cassinelli, Giuliana, Laura Dal Bo, Enrica Favini, et al.. (2017). Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases. Cancer Letters. 415. 187–197. 25 indexed citations
4.
Cassinelli, Giuliana, Enrica Favini, Laura Dal Bo, et al.. (2016). Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases. Oncotarget. 7(30). 47848–47863. 38 indexed citations
5.
Lopergolo, Alessia, Enrica Favini, Laura Dal Bo, et al.. (2013). Synergistic Cooperation Between Sunitinib and Cisplatin Promotes Apoptotic Cell Death in Human Medullary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 99(2). 498–509. 18 indexed citations
6.
Monti, Daniela, et al.. (2012). Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects. Journal of the European Academy of Dermatology and Venereology. 27(2). e153–8. 27 indexed citations
7.
Gatti, Laura, Kwang‐Lae Hoe, Jacqueline Hayles, et al.. (2011). Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast. BMC Genomics. 12(1). 44–44. 20 indexed citations
8.
Belluti, Federica, Gabriele Fontana, Laura Dal Bo, et al.. (2010). Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents. Bioorganic & Medicinal Chemistry. 18(10). 3543–3550. 210 indexed citations
9.
Supino, Rosanna, A. Ivana Scovassi, Anna Cleta Croce, et al.. (2009). Biological Effects of a New Vacuolar‐H,+‐ATPase Inhibitor in Colon Carcinoma Cell Lines. Annals of the New York Academy of Sciences. 1171(1). 606–616. 18 indexed citations
10.
Supino, Rosanna, Giovanna Petrangolini, Graziella Pratesi, et al.. (2007). Antimetastatic Effect of a Small-Molecule Vacuolar H+-ATPase Inhibitor in in Vitro and in Vivo Preclinical Studies. Journal of Pharmacology and Experimental Therapeutics. 324(1). 15–22. 26 indexed citations
11.
Righetti, Sabina Carla, Paola Perego, Nives Carenini, et al.. (2006). Molecular alterations of cells resistant to platinum drugs: Role of PKCα. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763(1). 93–100. 13 indexed citations
12.
Petrangolini, Giovanna, Rosanna Supino, Graziella Pratesi, et al.. (2006). Effect of a Novel Vacuolar-H+-ATPase Inhibitor on Cell and Tumor Response to Camptothecins. Journal of Pharmacology and Experimental Therapeutics. 318(3). 939–946. 34 indexed citations
13.
Perego, Paola, Laura Gatti, Sabina Carla Righetti, et al.. (2003). Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells. International Journal of Cancer. 105(5). 617–624. 39 indexed citations
14.
Supino, Rosanna, Donatella Polizzi, Graziella Pratesi, et al.. (2001). A Novel 9-Aza-Anthrapyrazole Effective against Human Prostatic Carcinoma Xenografts. Oncology. 61(3). 234–242. 13 indexed citations
15.
Mezzelani, Alessandra, Alessandra Fabbri, Laura Dal Bo, et al.. (2000). Analysis of SYT-SSX Fusion Transcripts and bcl-2 Expression and Phosphorylation Status in Synovial Sarcoma. Laboratory Investigation. 80(6). 805–813. 61 indexed citations
16.
Pratesi, Graziella, Donatella Polizzi, Paola Perego, Laura Dal Bo, & Franco Zunino. (2000). Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs. Biochemical Pharmacology. 60(1). 77–82. 22 indexed citations
17.
Perego, Paola, Laura Gatti, Nives Carenini, Laura Dal Bo, & Franco Zunino. (2000). Apoptosis induced by extracellular glutathione is mediated by H2O2 production and DNA damage. International Journal of Cancer. 87(3). 343–348. 17 indexed citations
18.
Pratesi, Graziella, Michelandrea De Cesare, Claudia Caserini, et al.. (1998). Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.. PubMed. 4(11). 2833–9. 30 indexed citations
19.
Binaschi, Monica, Giovanni Capranico, Laura Dal Bo, & Franco Zunino. (1997). Relationship between Lethal Effects and Topoisomerase II-Mediated Double-Stranded DNA Breaks Produced by Anthracyclines with Different Sequence Specificity. Molecular Pharmacology. 51(6). 1053–1059. 76 indexed citations
20.
Pratesi, Graziella, et al.. (1995). The role of the glutathione-dependent system in tumor sensitivity to cisplatin: A study of human tumor xenografts. Annals of Oncology. 6(3). 283–289. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026